Brain activation patterns of female multiple sclerosis patients with voiding dysfunction.
Adult
Aged
Aged, 80 and over
Brain
/ diagnostic imaging
Case-Control Studies
Cerebellum
/ diagnostic imaging
Female
Functional Neuroimaging
Gyrus Cinguli
/ diagnostic imaging
Humans
Lower Urinary Tract Symptoms
/ etiology
Magnetic Resonance Imaging
/ methods
Middle Aged
Multiple Sclerosis
/ complications
Periaqueductal Gray
/ diagnostic imaging
Pons
/ diagnostic imaging
Thalamus
/ diagnostic imaging
Urinary Bladder
/ physiopathology
Urinary Bladder, Neurogenic
/ etiology
Urination
/ physiology
Urination Disorders
/ etiology
Urodynamics
/ physiology
bladder
fMRI
incontinence
multiple sclerosis
urgency
Journal
Neurourology and urodynamics
ISSN: 1520-6777
Titre abrégé: Neurourol Urodyn
Pays: United States
ID NLM: 8303326
Informations de publication
Date de publication:
03 2020
03 2020
Historique:
received:
19
07
2019
accepted:
23
01
2020
pubmed:
8
2
2020
medline:
13
11
2020
entrez:
8
2
2020
Statut:
ppublish
Résumé
We compared brain activation patterns between female multiple sclerosis (MS) patients with voiding dysfunction (VD) and those without. We aim to expand current knowledge of supraspinal correlates of voiding initiation within a cohort of female MS patients with and without VD. Twenty-eight ambulatory female MS patients with stable disease and lower urinary tract dysfunction were recruited for this study. Subjects were divided into group 1, without VD (n = 14), and group 2, with VD (n = 14), defined as postvoid residual urine of ≥40% of maximum cystometric capacity or need for self-catheterization. We recorded brain activity via functional magnetic resonance imaging (fMRI) with simultaneous urodynamic testing. Average fMRI activation maps (the Student t test) were created for both groups, and areas of significant activation were identified (P < .05). A priori regions of interest (ROIs), identified by prior meta-analysis to be involved in voiding, were selected. Group-averaged blood-oxygen level-dependent (BOLD) activation maps demonstrated significant differences between groups 1 and 2 during initiation of voiding with group 2 showing significantly lower levels of activation in all ROIs except for the left cerebellum and right cingulate gyrus. Interestingly, group 2 displayed negative BOLD signals, while group 1 displayed positive signals in the right and left pontine micturition center, right periaqueductal gray, left thalamus, and left cingulate gyrus. The activation map of group 1 was similar to healthy controls. Our results support the hypothesis that distinct supraspinal activation patterns exist between female MS patients with VD and those without.
Identifiants
pubmed: 32032447
doi: 10.1002/nau.24304
pmc: PMC7337290
mid: NIHMS1558049
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
969-977Subventions
Organisme : NIDDK NIH HHS
ID : K23 DK118209
Pays : United States
Organisme : NIDDK NIH HHS
ID : K23DK118209
Pays : United States
Informations de copyright
© 2020 Wiley Periodicals, Inc.
Références
Neuroimage Clin. 2017 Sep 28;17:153-162
pubmed: 29071209
J Urol. 2017 Feb;197(2):438-444
pubmed: 27664581
Am J Obstet Gynecol. 2002 Jul;187(1):116-26
pubmed: 12114899
PLoS One. 2015 Aug 12;10(8):e0135428
pubmed: 26267665
Brain. 2000 Apr;123 ( Pt 4):781-9
pubmed: 10734009
Neuron. 2002 Dec 19;36(6):993-5
pubmed: 12495615
Am Fam Physician. 2013 May 15;87(10):712-4
pubmed: 23939450
Brain. 1997 Jan;120 ( Pt 1):111-21
pubmed: 9055802
Neurourol Urodyn. 2010;29(1):4-20
pubmed: 19941278
Nat Rev Urol. 2016 May;13(5):275-88
pubmed: 27030526
J Urol. 1998 Mar;159(3):972-6
pubmed: 9474196
Nat Rev Neurosci. 2008 Jun;9(6):453-66
pubmed: 18490916
Neurourol Urodyn. 2019 Jan;38(1):239-247
pubmed: 30311665
N Engl J Med. 2000 Sep 28;343(13):938-52
pubmed: 11006371
BJU Int. 2010 Feb;105(3):366-72
pubmed: 19735259
Curr Bladder Dysfunct Rep. 2019 Mar;14(1):24-30
pubmed: 31681452
J Neurophysiol. 2012 Nov;108(9):2339-42
pubmed: 22723671
J Urol. 2014 Oct;192(4):1149-54
pubmed: 24769029
Ann Neurol. 2017 Apr;81(4):479-484
pubmed: 28198092
Neuron. 2002 Dec 19;36(6):1195-210
pubmed: 12495632
J Midlife Health. 2014 Jul;5(3):104-10
pubmed: 25316994
J Urol. 1999 Mar;161(3):743-57
pubmed: 10022678
Brain. 1998 Nov;121 ( Pt 11):2033-42
pubmed: 9827764
J Cereb Blood Flow Metab. 2002 Aug;22(8):908-17
pubmed: 12172376
Int Urogynecol J Pelvic Floor Dysfunct. 1999;10(3):192-9
pubmed: 10430014
Brain. 2005 Sep;128(Pt 9):2146-53
pubmed: 15901646